HD-OPM Archive
Topics › Aging & longevity

Whole-blood NAD+ does not change with age or lifestyle, so it is a poor aging marker

Louis Nervegna · May 22, 2026 · ♥ 5 reactions · 4 comments · original Facebook post
Aging & longevitySupplements & vitamins
AI summary & key facts

Louis, echoing Charles Brenner, shares a Nature Metabolism paper reporting that human whole-blood NAD+ is stable across age and not altered by exercise or lifestyle interventions. Nicotinamide riboside raised NAD+, but that does not prove clinical or longevity benefit; tissue NAD matters.

As Charles Brenner has said for years, it is tissue levels of NAD that seem to matter.

Not blood levels.

Blood levels don’t seem to tell you anything useful, except how much vitamin B3 that you recently took (which you already know).

#nadHD #charlesbrennerHD #nmnHD #nrHD #niacinHD #nicotinamideHD #vitaminb3HD

Research cited

For years, the longevity industry has aggressively marketed the idea that NAD+ levels inevitably decline with age and that boosting NAD+ is a key to slowing aging.

Now a new paper in Nature Metabolism challenges one of the central assumptions behind this commercial narrative:

“Human whole-blood NAD+ levels do not vary with age or lifestyle interventions.”

The study analyzed multiple independent human cohorts using rigorous mass spectrometry methods and found that:

Yes, nicotinamide riboside supplementation increased NAD+ levels — as expected — but that alone does not prove meaningful clinical benefits, longevity effects, or rejuvenation.

This is an important reminder that:

The longevity field urgently needs:

Aging biology is extraordinarily complex. There are no magic molecules.

#Longevity #Aging #NAD #Science #EvidenceBasedMedicine #Metabolism #HealthyAging

No photo description available.
← newer: Even 'normal' vitamin B12 may be too low for older brains; aolder: Retatrutide phase 3 results: average 28% body weight loss in →